Navigation Links
Dendreon Reports Fourth Quarter and 2008 Year End Financial Results
Date:3/12/2009

CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share amounts) Three months ended Year ended December 31, December 31, 2008 2007 2008 2007 (unaudited) Revenue $28 $28 $111 $743 Operating expenses: Research and development 10,755 21,743 50,086 76,523 General and administrative 4,783 5,382 20,503 25,839 Total operating expenses 15,538 27,125 70,589 102,362 Loss from operations (15,510) (27,097) (70,478) (101,619) Interest income 712 1,717 3,619 6,461 Interest expense (1,161) (1,571) (5,156) (4,106) Gain from valuation of warrant liability 7,122 - 371 - Net loss ($8,837) ($26,951) ($71,644) ($99,264) Basic and diluted net loss per share ($0.09) ($0.32) ($0.79) ($1.20) Shares used in computation of basic and diluted net loss per share 95,109 83,051 90,357 82,531 December 31, December 31, 2008 2007 Balance Sheet Data: Cash and cash equivalents $59,523 $75,721 Short-term investments 45,638 27,115 Long-term investments 3,386 17,739 Total assets 147,204 161,662 Warrant liability 14,190 - Convertible senior subordinated Notes 85,2
'/>"/>
SOURCE Dendreon Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Dendreon Announces Webcast Presentation at UBS Life Sciences Conference
3. Dendreon Secures $130 Million Committed Equity Financing Facility
4. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
5. Dendreon Reports Third Quarter 2007 Financial Results
6. Dendreon Promotes Dr. Mark Frohlich to Senior Vice President of Clinical Affairs and Chief Medical Officer
7. Dendreon Announces Webcast Presentation at BIO CEO & Investor Conference
8. Dendreon Publishes Manuscript on CD54 as a Surrogate Marker of Antigen Presenting Cell Activation
9. -Dendreon to Hold Conference Call on Thursday, March 13, 2008 at 11:00 AM ET-
10. FDA Agrees to Amend Dendreons Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE
11. Dendreon Reports Fourth Quarter and 2007 Year End Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... FREMONT, Calif. , Oct. 30, 2014 /PRNewswire/ ... clinical-stage biopharmaceutical company focused on cardio-renal, gastrointestinal and ... third quarter 2014 financial results on Thursday, November ... team will host a live conference call and ... financial results and provide a business update. ...
(Date:10/30/2014)... 2014 Deep Research Report on Global ... and in-depth research report on the China Naltrexone ... including its definition, classification, application, and industry chain ... covers the international market analysis, including China’s domestic ... macroeconomic environment & economic situation analysis. The report ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 ... collaboration provider, offers Office 365 end users the ... a complete phone system by adding voice enablement ... (O365) includes Lync Online, a communication tool that ... calls. With hosted voice, O365 becomes a comprehensive ...
(Date:10/30/2014)... October 30, 2014 James Sherley says he ... adult tissue stem cell technology since his days as a ... Philadelphia in the late 1990’s. Sherley founded the ASCTC ... company holds all the intellectual property developed in Sherley’s research ... the Massachusetts Institute of Technology (MIT), and more recently as ...
Breaking Biology Technology:Ardelyx to Report Third Quarter 2014 Financial Results on November 6, 2014 2Naltrexone HCL Market & Nalbuphine HCL Industry Analysis for Global, China Regions Now at DeepResearchReports.com 2Naltrexone HCL Market & Nalbuphine HCL Industry Analysis for Global, China Regions Now at DeepResearchReports.com 3SoundConnect Launches Voice Enablement and Hybrid Audio Conferencing for Office 365 2SoundConnect Launches Voice Enablement and Hybrid Audio Conferencing for Office 365 3Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 2Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 3Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 4
... 30 ChemRisk, a leading scientific,consulting firm, was ... examine,the recent publication by Institute for Agriculture and ... High Fructose Corn Syrup," and the,Environmental Health journal ... product sugar," by Dufault et al, 2009, and ...
... risk factors better than standard cholesterol test and traditional ... Traditional risk factors such as age, standard cholesterol ... predicting heart disease risk in younger, healthy adults with ... to a recent study published in Clinical Cardiology ...
... Mass., Jan. 30 Jeff Olson, Manager of Nucleic ... Enrichment of Genomic Loci for Targeted Sequencing Applications ... RainStorm micro-droplet technology on the new RDT 1000 instrument, ... (AGBT) conference on Friday, February 6th, in Marco Island, ...
Cached Biology Technology:Recent Reports Regarding Mercury and High Fructose Corn Syrup Flawed and Misleading 2Recent Reports Regarding Mercury and High Fructose Corn Syrup Flawed and Misleading 3Recent Reports Regarding Mercury and High Fructose Corn Syrup Flawed and Misleading 4Traditional Risk Factors Often Miss Heart Disease Warning Signs 2Traditional Risk Factors Often Miss Heart Disease Warning Signs 3Traditional Risk Factors Often Miss Heart Disease Warning Signs 4'Enrichment of Genomic Loci for Targeted Sequencing Application' Is Focus of 2009 AGBT Conference Workshop 2'Enrichment of Genomic Loci for Targeted Sequencing Application' Is Focus of 2009 AGBT Conference Workshop 3
(Date:10/29/2014)... rage. Thousands of scientists worldwide are conducting research on ... nanoparticles from sun creams can get through the skin ... products are as hazardous for the lungs as asbestos ... get into the blood via the intestinal flora, for ... – and the number of scientific projects is skyrocketing: ...
(Date:10/29/2014)... to as ,facultative, form part—together with other cells—of tissues ... cells from the others. However, they have a very ... stem cells again. This phenomenon is something that happens ... stimulate tissue growth, thus allowing the regeneration of the ... the underlying mechanism that allows these cells to ...
(Date:10/29/2014)... – Ghrelin is a hormone released by the stomach ... commonly viewed as a psychoactive substance that primarily affects ... food. , This knowledge, combined with findings from ... has the potential to stimulate alcohol craving. , Dr. ... and found that, as they had anticipated, alcohol craving ...
Breaking Biology News(10 mins):Nanosafety research: The quest for the gold standard 2Nanosafety research: The quest for the gold standard 3A mechanism that allows a differentiated cell to reactivate as a stem cell revealed 2Ghrelin stimulates an appetite for drinking alcohol 2
... VEGAS , Jan. 7, 2014 from ShowStoppers @ ... of securing consumer data on mobile and other digital devices, ... data once it leaves the device and enters the cloud. ... announced the formalization of its Biometric Open Standards Protocols (BOPS). ...
... This news release is available in Portuguese . ... is available in Portuguese . , ... goes beyond the presence or absence of wings. In a study published ... Keller and Patrcia Beldade from the Instituto Gulbenkian de Cincia (IGC, ...
... underrepresented among speakers at scientific meetings, both in absolute ... a new study suggests one way to address this ... published in mBio , the online open-access journal ... inclusion of at least one woman on a convening ...
Cached Biology News:Hoyos Labs Issues Biometric Open Protocol Standard for Safer Authentication 2Hoyos Labs Issues Biometric Open Protocol Standard for Safer Authentication 3Ants shape their thoraces to match the tasks they perform 2Ants shape their thoraces to match the tasks they perform 3Including women on convening committees increases women speakers at scientific meetings 2
Troponin I Immunogen: Full length native protein (purified) (Human). Storage: -20 C, Avoid Freeze/Thaw Cycles...
...
Microlite 1+ 1x12 Strip assembled, flat bottom; the ideal vessel for low signal luminescent reactions, offering medium binding with enhanced dynamic range, extra high reflectivity and minimal cross t...
... pressurized syringe holder for any researcher who needs: ... Microinjecting Fine microliter delivery Small ... any new or existing perfusion rig - from ... to house air or a compressor (30 to ...
Biology Products: